Citigroup Inc. Acquires 2,989 Shares of Mettler-Toledo International, Inc. $MTD

Citigroup Inc. grew its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 4.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 65,033 shares of the medical instruments supplier’s stock after acquiring an additional 2,989 shares during the quarter. Citigroup Inc. owned 0.32% of Mettler-Toledo International worth $79,835,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Tredje AP fonden raised its position in Mettler-Toledo International by 28.6% in the 3rd quarter. Tredje AP fonden now owns 2,407 shares of the medical instruments supplier’s stock worth $2,955,000 after purchasing an additional 535 shares during the period. Stevens Capital Management LP purchased a new stake in Mettler-Toledo International during the third quarter valued at about $438,000. Syon Capital LLC grew its stake in shares of Mettler-Toledo International by 35.8% during the third quarter. Syon Capital LLC now owns 273 shares of the medical instruments supplier’s stock valued at $335,000 after buying an additional 72 shares during the last quarter. NEOS Investment Management LLC increased its holdings in shares of Mettler-Toledo International by 87.7% in the third quarter. NEOS Investment Management LLC now owns 565 shares of the medical instruments supplier’s stock worth $694,000 after buying an additional 264 shares during the period. Finally, Merit Financial Group LLC lifted its stake in shares of Mettler-Toledo International by 12.3% in the 3rd quarter. Merit Financial Group LLC now owns 920 shares of the medical instruments supplier’s stock valued at $1,129,000 after acquiring an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Barclays decreased their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a report on Monday, December 15th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a research note on Monday, December 15th. Finally, The Goldman Sachs Group initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,435.42.

Insider Buying and Selling

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,055 shares of the stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total transaction of $9,010,929.90. Following the sale, the insider directly owned 187 shares in the company, valued at approximately $278,289.66. This trade represents a 97.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Shawn Vadala sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $1,511.00, for a total transaction of $1,511,000.00. Following the sale, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,990,168. The trade was a 15.90% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 7,855 shares of company stock valued at $11,650,026. 0.77% of the stock is owned by corporate insiders.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,377.04 on Monday. The firm’s 50-day moving average price is $1,413.42 and its 200-day moving average price is $1,369.50. The company has a market capitalization of $28.00 billion, a PE ratio of 32.69, a P/E/G ratio of 2.89 and a beta of 1.42. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, topping the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The business had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the previous year, the firm posted $12.41 earnings per share. Mettler-Toledo International’s quarterly revenue was up 8.1% on a year-over-year basis. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Equities analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.